Skip to search formSkip to main contentSkip to account menu

CGS 20625

Known as: CGS-20625 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Oral absorption of CGS-20625, an insoluble drug, in dogs and man
Oral bioavailability of highly water-insoluble drugs is often quite limited and variable, requiring the development of improved… 
1991
1991
Determination of a potential anxiolytic drug (CGS 20625) in human plasma by high-performance liquid chromatography.
1990
1990
CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity.
1989
1989
CGS 20625, a novel pyrazolopyridine anxiolytic.
CGS 20625 (2-(4-methoxyphenyl)2,3,5,6,7,8,9,10-octa hydrocyclohepta[b]pyrazolo-[3,4-d]pyridin-3-one) is a potent and selective… 
Review
1987
Review
1987
Pharmacology of the pyrazolo-type compounds: Agonist, antagonist and inverse agonist actions
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)